Jean-marc M. Bereder - Publications

The clinical benefit of a near complete cytoreduction in patients with colorectal peritoneal metastases: a propensity score matched study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: November 13, 2025

Assessing the Annual Risk of Recurrence Following Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Diffuse Malignant Peritoneal Mesothelioma Patients.

Journal: Annals of surgical oncology

Published: September 13, 2024

Role of Hyperthermic Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery as Consolidation Therapy for Advanced Epithelial Ovarian Cancer.

Journal: Annals of surgical oncology

Published: August 23, 2022

Delaying Surgery After Neoadjuvant Chemotherapy Affects Survival in Patients with Colorectal Peritoneal Metastases: A BIG-RENAPE Network Multicentric Study.

Journal: Annals of surgical oncology

Published: July 14, 2022

Preoperative prognostic factors for obstructive colorectal cancer.

Journal: International journal of colorectal disease

Published: April 17, 2022

Prognosis of poorly cohesive gastric cancer after complete cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CYTO-CHIP study).

Journal: The British journal of surgery

Published: January 08, 2021

Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study.

Journal: The Lancet. Oncology

Published: March 03, 2020

Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center.

Journal: Surgical endoscopy

Published: June 13, 2019

Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 16, 2019

Can machine learning predict resecability of a peritoneal carcinomatosis?

Journal: Surgical oncology

Published: February 24, 2019

Well differentiated papillary peritoneal mesothelioma treated by cytoreduction and hyperthermic intraperitoneal chemotherapy-the experience of the PSOGI registry.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: September 10, 2018

Well-Differentiated Papillary Mesothelioma of the Peritoneum: A Retrospective Study from the RENAPE Observational Registry.

Journal: Annals of surgical oncology

Published: August 02, 2018